Kevin Krenzke

Kevin Krenzke is a seasoned financial executive with extensive experience in various leadership roles across the healthcare and financial sectors. Currently serving as Chief Financial Officer at Ob Hospitalist Group since September 2015, Kevin has previously held senior positions at notable organizations, including Executive Vice President of Finance and Administration at MolecularHealth and Chief Financial Officer at Florida Cancer Specialists. Kevin's expertise also includes serving as Vice President of Finance and Merger Integration Lead at McKesson, where oversight of the merger between US Oncology and McKesson Specialty Care Solutions was a key responsibility. Kevin's career began at Arthur Andersen LLP and includes significant roles at Deloitte and BDO Seidman, LLP, culminating in their role as Chief Accounting Officer at US Oncology. Kevin holds a Master in Professional Accounting from the Texas McCombs School of Business at The University of Texas at Austin.